Paliperidone Palmitate Long Acting Injection (Under development)

Paliperidone Palmitate Long Acting Injection (Under development)
Product Description

Ingridient: Paliperidone Palmitate

Dosage form: Lyophilized long acting injection (monthly)

Indication: Treatment of schizophrenia in adults and treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.

Read more Show less

Anxo Pharmaceutical Co.

  • TW
  • 2021
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Taiwan, China
More specifications Fewer specifications
Sales Markets
Show more Show less

Anxo Pharmaceutical Co.

  • TW
  • 2021
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
View company profile

More Products from Anxo Pharmaceutical Co. (2)

  • Berydone 3/ 6/ 9 mg (Paliperidone)

    Product Berydone 3/ 6/ 9 mg (Paliperidone)

    Ingridient: Paliperidone 3mg/tab, Paliperidone 6mg/tab, Paliperidone 9mg/tab

    Dosage form:Controlled Osmotic Release System ER Tablet

    Indication:Atypical antipsychotic agent indicated for Treatment of schizophrenia
  • Nophos F.C. Tablet 800mg (Sevelamer Carbonate)

    Product Nophos F.C. Tablet 800mg (Sevelamer Carbonate)

    Ingridient: Sevelamer 800mg 
    Dosage form: FC Tablet

    Indication: Nophos is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis